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INTRODUCTION
In early animal development, the temporal and spatial
expression of maternally inherited mRNA is necessary for
processes as diverse as oocyte maturation (Sheets et al., 1994;
Stebbins-Boaz et al., 1996; Mendez et al., 2000a), embryonic
cleavage (Groisman et al., 2000; Uto and Sagata, 2000) and
establishment of the body plan (Simon et al., 1996; Wu et al.,
1997; Schroeder et al., 1999; Carrera et al., 2000). One
mechanism responsible for the translational activation of
several maternal messages is cytoplasmic polyadenylation,
which has been studied most extensively in Xenopus oocytes.
In this species, several mRNAs that are dormant in oocytes
have short poly(A) tails, usually ~20 nucleotides in length.
After the induction of oocyte maturation by progesterone,
some of these mRNAs undergo cytoplasmic polyadenylation-
induced translation (McGrew et al., 1989; Sheets et al., 1995;
Stebbins-Boaz et al., 1996). Two cis elements in the 3 ¢
untranslated region of responding mRNAs direct cytoplasmic
polyadenylation, the cytoplasmic polyadenylation element
(CPE) and the polyadenylation hexanucleotide AAUAAA (Fox
et al., 1989; McGrew et al., 1989). The CPE is bound by CPEB,
a zinc finger and a RNA recognition motif (RRM)-containing
protein (Paris et al., 1991; Hake and Richter, 1994; Hake et al.,
1998), while the hexanucleotide is bound by a cytoplasmic
form of cleavage and polyadenylation specificity factor (CPSF)
(Bilger et al., 1994; Dickson et al., 1999). The stimulation of
polyadenylation is most probably due to the kinase Eg2, which
is activated soon after oocytes are exposed to progesterone
(Andresson and Ruderman, 1998). Eg2 phosphorylates CPEB
Ser174, which resides within an LDS/TR motif that is
conserved among other vertebrate CPEB proteins (Mendez et
al., 2000a). Once phosphorylated on this residue, CPEB
recruits CPSF and poly(A) polymerase (PAP) into an active
polyadenylation complex (Mendez et al., 2000b).
While the core features of cytoplasmic polyadenylation
have been elucidated, they do not indicate a priori how
polyadenylation stimulates translation. The mechanism of
translational activation was suggested by initial studies
demonstrating that the CPE, which is necessary for
polyadenylation during maturation, also mediates translational
repression (masking) prior to maturation (de Moor and Richter,
1999). The studies implied that CPEB, the only factor
identified that could bind the CPE, activated and repressed
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In both vertebrates and invertebrates, the expression of
several maternal mRNAs is regulated by cytoplasmic
polyadenylation. In Xenopus oocytes, where most of the
biochemical details of this process have been examined,
polyadenylation is controlled by CPEB, a sequence-specific
RNA binding protein. The activity of CPEB, which is to
recruit cleavage and polyadenylation specificity factor
(CPSF) and poly(A) polymerase (PAP) into an active
cytoplasmic polyadenylation complex, is controlled by
Eg2-catalyzed phosphorylation. Soon after CPEB
phosphorylation and resulting polyadenylation take place,
the interaction between maskin, a CPEB-associated factor,
and eIF4E, the cap-binding protein, is destroyed, which
results in the recruitment of mRNA into polysomes.
Polyadenylation also occurs in maturing mouse oocytes,
although the biochemical events that govern the reaction in
these cells are not known. In this study, we have examined
the phosphorylation of CPEB and have assessed the
necessity of this protein for polyadenylation in maturing
mouse oocytes. Immunohistochemistry has revealed that all
the factors that control polyadenylation and translation in
Xenopus oocytes (CPEB, CPSF, PAP, maskin, and IAK1,
the murine homologue of Eg2) are also present in the
cytoplasm of mouse oocytes. After the induction of
maturation, a kinase is activated that phosphorylates
CPEB on a critical regulatory residue, an event that is
essential for CPEB activity. A peptide that competitively
inhibits the activity of IAK1/Eg2 blocks the progression of
meiosis in injected oocytes. Finally, a CPEB protein that
acts as a dominant negative mutation because it cannot
be phosphorylated by IAK1/Eg2, prevents cytoplasmic
polyadenylation. These data indicate that cytoplasmic
polyadenylation in mouse oocytes is mediated by
IAK1/Eg2-catalyzed phosphorylation of CPEB.
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translation. How CPEB could act both positively and
negatively was indicated when maskin, a CPEB-interacting
factor, was identified (Stebbins-Boaz et al., 1999). In oocytes,
maskin not only binds CPEB, but also the cap-binding protein
eIF4E. This configuration of factors excludes the interaction
between eIF4E and eIF4G, which is essential for cap-
dependent translation (for a discussion of initiation factors,
see Gingras et al., 1999). During oocyte maturation at a time
commensurate with polyadenylation, the interaction between
maskin and eIF4E is disrupted, which presumably then allows
eIF4G to bind eIF4E and promote initiation (Stebbins-Boaz et
al., 1999). It seems plausible that polyadenylation could be
involved in the dissociation of maskin from eIF4E. It should
also be borne in mind that polyadenylation might also stimulate
translation in a maskin-independent manner, for example, by
inducing cap-specific 2 ¢ -o-methylation (Kuge and Richter,
1995).
Cytoplasmic polyadenylation also takes place in maturing
mouse oocytes, where at least some of the key features are
similar to those described in Xenopus. For example, the CPE
and AAUAAA drive polyadenylation-induced translation
(Vassalli et al., 1989; Huarte et al., 1992, Gebauer et al., 1994;
Tay et al., 2000; Oh et al., 2000). In addition, the CPE (also
referred to as the ACE, or adenylation control element) also
represses translation before maturation (Stutz et al., 1997; Stutz
et al., 1998; Tay et al., 2000), as is the case in Xenopus.
However, aside from the fact that mouse oocytes contain
CPEB (Gebauer and Richter, 1996; Tay et al., 2000), and that
polyadenylation is important for meiotic progression (Gebauer
et al., 1994; Tay et al., 2000), little is known about the
biochemical features of the process in these species.
In this study, we have analyzed the molecules that mediate
cytoplasmic polyadenylation in maturing mouse oocytes. All
the factors that are involved in this process in Xenopus (CPEB,
CPSF, PAP, maskin, IAK1/Eg2) are also present in the
cytoplasm of mouse oocytes. After the induction of oocyte
maturation, a kinase becomes active that phosphorylates
CPEB Ser174, an event that is crucial for cytoplasmic
polyadenylation. The injection of a peptide that is known to
block the activity of IAK1/Eg2 impedes meiotic progression.
Furthermore, the injection of an mRNA encoding a truncated
form of CPEB, which acts as a dominant negative mutation
because it cannot be phosphorylated by IAK1/Eg2, inhibits
cytoplasmic polyadenylation. These data indicate that
IAK1/Eg2 and CPEB are essential components for cytoplasmic
polyadenylation in mouse oocytes.
MATERIALS AND METHODS
Collection and culture of oocytes
Germinal vesicle (GV) stage cumulus-enclosed oocytes from 19-21
day CD-1 mice (Harlan Sprague-Dawley) were isolated in phosphate-
buffered saline containing isobutylmethylxanthine (IBMX, 0.15 mM)
and polyvinylpyrrolidone (3 mg/ml; Mr, 40,000), and the cumulus
cells removed by mechanical shearing. After collection, the oocytes
were washed with M16 medium supplemented with 10% fetal calf
serum and 0.3% bovine serum albumin.
Analysis of polyadenylation
[32P]UTP-labeled murine cyclin 3 ¢ UTR (plus or minus the CPE),
radioinert Xenopus full-length wild-type CPEB and D N CPEB,
which lacks residues 1-146 (Mendez et al., 2000a), were synthesized
in vitro by T3 or T7 RNA polymerase. Depending on the
experiment, the labeled RNA (~6 · 106 cpm/ m l) alone was injected
into GV stage oocytes, or was mixed with the unlabeled RNAs (0.7
mg/ml, equal volumes) before injection (~10 pl per injection). The
oocytes were cultured in the presence of isobutylmethylxanthine
(IBMX) for 6 hours, after which time they were washed in IBMX-
free medium and cultured for an additional 16-17 hours. RNA was
then extracted from the oocytes according to Tay et al. (Tay et al.,
2000), and the RNA was resolved on a 6% polyacrylamide gel
containing 8 M urea and phosphorimaged.
Analysis of polyadenylation factors
Whole-mount immunohistochemistry was performed as described by
Messinger and Albertini (Messinger and Albertini, 1991). Briefly,
oocytes were fixed in 100 mM Pipes, 5 mM MgCl, 2.5 mM EGTA,
0.1% aprotinin, 1 mM DTT, 50% D2O, 1 m M taxol, 0.1% Triton X-
100 and 2% formaldehyde for 20 minutes at 37°C, and then blocked
in phosphate-buffered saline containing 2% BSA, 2% powdered milk,
2% goat serum and 0.1% Triton X-100 for 30 minutes at room
temperature. The antibodies (1:100 dilution) directed against murine
CPEB (Tay et al., 2000), Xenopus maskin (Stebbins-Boaz et al.,
1999), CPSF100 (Mendez et al., 2000b), IAK1 (Transduction
Laboratories) and Xenopus PAP (Gebauer and Richter, 1995) were
added to the blocking buffer and the oocytes were incubated at 37°C
for 1 hour with gentle rotation. After washing with the blocking
solution, the secondary fluorophore-labeled antibody (1:1000), which
was either Alexa 488 goat anti-mouse IgG or Alexa 594 goat anti-
rabbit IgG (Molecular probes) was added, again in blocking buffer.
The oocytes were also simultaneously stained with DAPI. Western
blots were probed with the antibodies noted above; for CPEB, 110
GV oocytes were analyzed, 250 oocytes for maskin, 535 oocytes for
CPSF100, 180 oocytes for IAK1 and 200 oocytes for poly(A)
polymerase.
Analysis of CPEB phosphorylation
Peptides spanning a region from murine CPEB that contains the LDS/
TR motif that is recognized by IAK1/Eg2 (RGSRLDTRPILDSRSSC),
or a mutant sequence with alanine for serine substitutions
(RGSRLDARPILDARSSC), which cannot be phosphorylated by this
kinase (Mendez et al., 2000a) were coupled to maleimide-activated
ovalbumin (Pierce). The conjugates were added to extracts prepared
as follows. 50 GV, GVBD (MI) or MII stage oocytes were frozen and
thawed three times in 4.25 m l of buffer (Hampl and Eppig, 1995a) that
contained 125 mM Mops, pH 7.2, 300 mM b -glycerophosphate, 2 mg
p-nitrophenylphosphate, 7.5 mM EGTA, 0.5 mM Na3VO4, 75 mM
MgCl, 5 mM dithiothreitol, 10 m g/ml each of aprotinin, soybean
trypsin inhibitor, pepstatin A and leupeptin, and 25 m g BSA). After
brief centrifugation, 10 m l of wild-type or mutant peptide conjugated
to ovalbumin was to the supernatant, together with 1 m Ci [g -32P]ATP
1 mM phenylmethylsulfonyl fluoride, and 0.025 m g protein kinase A
inhibitor (final reaction volume of 30 m l). The solution was incubated
for 1 hr at 30°C and then analyzed by 12% PAGE.
For the phosphopeptide mapping, purified baculovirus-expressed
Xenopus CPEB was added to extracts made as described above, but
in this case from 600 MI stage oocytes. The entire extract was then
resolved by 8% SDS PAGE and CPEB was electroblotted onto nylon
membrane and digested with trypsin. The 2D phosphopeptide
mapping procedure has been described (Boyle et al., 1991; Mendez
et al., 2000a). In addition, CPEB was phosphorylated in vitro with
purified baculovirus expressed Xenopus Eg2, and the phosphopeptide
map was similarly derived.
Some oocytes were injected with ovalbumin-coupled wild-type and
mutant peptides (as noted above). In this case, the peptides were
brought up to a concentration of ~5 mg/ml, and ~10 pl was injected
per oocyte. The oocytes were incubated for up to 10 hours, and were
scored for the presence or absence of the first polar body.
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RESULTS
Polyadenylation and meiotic progression
Cytoplasmic polyadenylation of cyclin B1 mRNA takes place
during mouse oocyte maturation and is detectable as early as
metaphase I, which occurs within 6 hours of culture (Tay et
al., 2000). While the assay used to detect this polyadenylation
is sensitive (the PCR-based PAT assay, Salles et al., 1994), it
can miss some poly(A) lengthening if the existing poly(A) tail
on the substrate mRNA is under ~20 nucleotides, which is too
short to anneal with oligo (dT) and thus would not be reverse
transcribed. Consequently, we injected 32P-labeled cyclin 3 ¢
UTR that was devoid of an existing tail into oocytes, and
directly determined polyadenylation by gel electrophoresis
and phosphorimaging. Fig. 1 shows that polyadenylation of
the CPE-containing RNA was detectable as early as three
hours post-injection. An identical RNA that had the CPE
deleted did not undergo cytoplasmic polyadenylation.
Therefore, cytoplasmic polyadenylation occurs before
germinal vesicle breakdown, and implies that all the factors
that are necessary for this process are stored in the cytoplasm
of oocytes.
Multiple polyadenylation factors are cytoplasmic in
mouse oocytes
Polyadenylation-induced translation in Xenopus oocytes
requires CPEB, CPSF, PAP, maskin and the kinase Eg2, whose
murine homolog is IAK1 (Stk6 – Mouse Genome Informatics).
In full grown oocytes, CPEB and maskin are localized to the
animal pole while in embryos these factors, as well as Eg2, are
found on spindles and/or centrosomes (Groisman et al., 2000;
Giet and Prigent, 1999). Of these factors, only CPEB has been
linked with cytoplasmic polyadenylation in mouse oocytes, and
none have been examined for localization (Gebauer and
Richter, 1996; Tay et al., 2000). To assess whether these factors
are present in the cytoplasm of mouse oocytes and, if so,
whether they are localized in patterns similar to those observed
Fig. 2. Immunohistochemistry of
polyadenylation/translation factors
in maturing mouse oocytes. Oocytes
with an intact GV, or those cultured
for 6 (usually at MI), or 16.5 (MII)
hours were immunostained with
antibodies directed against CPEB,
IAK1 (Eg2), the 100 kDa subunit of
CPSF, PAP and maskin (the signals
for these proteins are red; IAKI is in
green). The oocytes were also
counterstained with DAPI (blue).
Each immunostaining procedure
was performed on at least 30
oocytes. Western blots of GV stage
oocyte protein were probed with the
same antibodies noted above; in
each case, only a single
immunoreactive species was
observed. No signal was observed in
either the immunofluorescence
experiment or in the western blot
experiment when preimmune serum
was used as the source for the first
antibody (data not shown).
Fig. 1. Polyadenylation in maturing mouse oocytes. Radiolabeled 3 ¢
UTR of cyclin B1 mRNA, which contains a CPE and
polyadenylation hexanucleotide (top) was injected into GV stage
oocytes that were then allowed to mature for 16.5 hours (center), or
for 3 (GV intact) and 6 (GVBD) hours (right). The RNA was
extracted and assessed by denaturing PAGE and phosphorimaging.
The approximate size of the newly acquired poly(A) tail is indicted.
As a control, a mutated cyclin B1 3¢ UTR that did not contain a CPE
was also injected and the oocytes were analyzed after 16.5 hours of
culture. For this experiment, the left panel represents 21 oocytes
(- CPE), the middle panel 87 oocytes (+CPE), and the right panel 31
(0 hours), 27 (3 hours) and 25 (6 hours) oocytes. All analyses were
performed twice.
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in Xenopus oocytes, whole-mount immunohistochemistry was
performed. Fig. 2 shows that CPEB immunoreactivity was
detectable at all stages of oogenesis throughout the oocyte.
IAK1/Eg2 was also detected throughout the oocyte at the GV
stage, but at MI and MII, it was virtually exclusively localized
to spindles. This observation is not unexpected because
members of this family of kinases are often spindle-associated
(Nigg, 2001). CPSF100, PAP and maskin immunoreactivities
were observed thought the oocyte at all stages of maturation
(Fig. 2). Western blots of GV stage extracts probed with the
antibodies noted above demonstrate that only a single species
of protein was detected in each case. With one exception, the
sizes of these immunoreactive species were those predicted
based on experiments performed with Xenopus material; the
size of the maskin immunoreactive band, however, was
somewhat smaller in the mouse, 120 kDa versus 150 kDa in
Xenopus. The data in Fig. 2 show that all the factors that are
thought to play key roles in polyadenylation-induced
translation are stored in the cytoplasm of oocytes before
maturation. However, in contrast to the situation in Xenopus
oocytes (Groisman et al., 2000), these results demonstrate that
there is little subcellular localization of these factors in mouse
oocytes.
Phosphorylation of CPEB
The Eg2 catalyzed phosphorylation of Xenopus CPEB Ser174
is necessary for cytoplasmic polyadenylation (Mendez et al.,
2000a). All known vertebrate CPEB proteins contain two
copies of the highly conserved LDS/T*R motif (Fig. 3A), the
phosphorylation sequence for IAK1/Eg2 (Mendez et al.,
2000a). Having demonstrated that mouse oocytes contain
IAK1/Eg2, we sought to determine whether murine CPEB is
also phosphorylated on this critical residue and, if so, whether
it is necessary for cytoplasmic polyadenylation. However,
because of the practical restriction in obtaining sufficient
quantities of maturing mouse oocytes for 2D phosphopeptide
mapping of endogenous CPEB, we have taken an alternative
approach. That is, while extracts of maturing oocytes have
detectable levels of kinase activity (see below), the putative
endogenous substrate (i.e. CPEB) is present in too limited an
amount for biochemical analysis. Consequently, we have
supplemented extracts with either a peptide derived from
CPEB, or Escherichia coli-expressed CPEB, which would
serve as substrates for the phosphorylation reaction. In
Xenopus oocytes, this approach has shown that exogenous and
endogenous CPEB substrate proteins are phosphorylated in an
identical manner (Mendez et al., 2000a).
R. Hodgman and others
Fig. 3. Phosphorylation of CPEB. (A) A
selected alignment of vertebrate CPEB
proteins containing the two conserved
LDS/TR motifs. Asterisks denote
consensus IAK1/Eg2 phosphorylation
sites. (B) Sequences of wild-type and
mutant IAK1/Eg2 substrate peptides
derived from mouse CPEB. The C-
terminal cysteine is not found in CPEB,
but was added to the peptide so it could
be coupled to ovalbumin.
(C) Phosphorylation of substrate peptide
during mouse oocyte maturation. The
peptides noted above were coupled to
ovalbumin and added to extracts prepared
from GV, MI and MII stage mouse
oocytes that were supplemented with
[g -32P]ATP. After incubation, the
radioactive products were analyzed by
SDS-PAGE. (D) 2D phosphopeptide
mapping of CPEB. Escherichia coli-
expressed Xenopus CPEB was added to
extracts prepared from GV or MI stage
mouse oocytes that were supplemented
with [g -32P]ATP. After incubation, the
products were resolved by SDS-PAGE
and CPEB was electroblotted onto PVDF
membrane. CPEB was then digested with
TPCK-treated trypsin and the resulting
phosphopeptides were resolved in two
dimensions. The asterisk denotes the
origin. In the top panel, ‘X’ denotes an area of the chromatogram that is unoccupied by a
phosphopeptide. A new phosphopeptide appears in this region when MI oocytes are used as
the kinase source. Purified recombinant CPEB was also phosphorylated in vitro by pure
baculovirus-expressed Eg2. The resulting phosphopeptide map reveals a single predominant
spot (arrow) corresponding to the first LDSR motif in CPEB, and was identified by amino
acid sequencing (Mendez et al., 2000a). A mix of the two tryptic digests (i.e. kinase sources
were MI oocytes and recombinant Eg2) before the 2D mapping reveals co-migration of the
LDSR phosphopeptides (arrow).
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Extracts prepared from GV, MI and MII stage oocytes were
supplemented with [g -32P]ATP and primed with two CPEB-
derived peptides covalently linked to ovalbumin. The first
peptide encompassed the two potential sites of phosphorylation
by IAK1/Eg2, while the second peptide contained mutations in
the highly conserved S and T residues (Fig. 3B). Although
neither peptide was phosphorylated in GV stage extracts,
the wild-type peptide was phosphorylated at MI, but only
slightly at MII (Fig. 3C). The mutant peptide, however, was
phosphorylated much less than wild type in MI stage extracts,
and again was only slightly phosphorylated at MII. These data
suggest that the kinase activity that is most prevalent at MI
preferentially phosphorylates the T and S residues present in
the LDS/TR motifs.
In order to define more precisely the target sites on CPEB
for the MI kinase activity noted above, 2D phosphopeptide
mapping was performed. In this case, the substrate was
purified recombinant Xenopus CPEB, because mouse CPEB
is insoluble after bacterial expression. At the GV stage, there
were relatively few sites of CPEB phosphorylation, and even
these were close to background levels (Fig. 3D). At MI,
however, several sites were phosphorylated, including one
that corresponded to the main LDS/TR phosphorylation site,
which is clearly shown by the position of this spot compared
with the position of the main site of CPEB phosphorylation
when purified baculovirus expressed Eg2 was used as
the kinase source (Fig. 3, arrows). To confirm that this
phosphopeptide is indeed the same one as that detected when
recombinant Eg2 was the kinase source, aliquots of the two
reactions were mixed before the 2D mapping (Fig. 3D). Co-
migration of the two spots demonstrates that CPEB is in
fact phosphorylated on Ser174 by a mouse oocyte kinase.
Therefore, mouse oocytes contain a developmentally
regulated kinase activity that closely matches that predicted
for IAK1/Eg2 in which CPEB is phosphorylated on the
critical residue that is necessary for cytoplasmic
polyadenylation. In this regard, it is worth noting that in
Xenopus oocytes, Eg2 is the only kinase that phosphorylates
CPEB Ser 174.
An IAK1/Eg2 blocking peptide inhibits polar body
formation
We next examined whether the IAK1/Eg2 kinase activity is
involved in oocyte maturation in the mouse. GV stage oocytes
were injected with a CPEB-derived peptide (Fig. 3B) that
specifically blocks Eg2 kinase activity and thereby inhibits
Xenopus oocyte maturation (Mendez et al., 2000a). Fig. 4
shows that this peptide only minimally slowed the rate of first
polar body formation compared with uninjected controls. In
Xenopus, this wild-type peptide also only slowed, but did not
block, meiotic progression (Mendez et al., 2000a). However,
in Xenopus, the mutant alanine-containing peptide (Fig. 3B)
dramatically inhibited maturation in injected oocytes. The
interpretation of these results is that while Eg2 binds both the
wild-type and mutant peptides, once the wild-type peptide is
phosphorylated, these molecules then dissociate and the
kinase is free to phosphorylate another substrate peptide (i.e.
the wild-type peptide is a competitive inhibitor). However,
because Eg2 cannot phosphorylate the mutant peptide, the
molecules remain attached, thereby irreversibly lowering the
effective concentration of the kinase (i.e. the mutant peptide
is a dominant inhibitor). Therefore, the mutant peptide would
be expected to be the most efficacious in abrogating Eg2-
dependent meiotic progression, which is the case observed in
injected mouse oocytes (Fig. 4).
A truncated CPEB that is not phosphorylated by
IAK1/Eg2 acts as dominant negative protein in
mouse oocytes
We have shown that two mutated CPEBs act as dominant
negative proteins and inhibit polyadenylation and meiotic
progression in Xenopus oocytes. The first mutant has had
both serines in the LDS/TR motif mutated to alanine. This
protein cannot be phosphorylated by IAK1/Eg2, and inhibits
polyadenylation-induced translation. The second mutant
CPEB has both LDS/TR motifs intact, but lacks the N-
terminal 146 residues that are involved in the CPEB-
IAK1/Eg2 interaction (CPEB D N). Hence, this protein is also
not phosphorylated by IAK1/Eg2 (Mendez et al., 2000a). To
determine whether a truncated CPEB acts as a dominant
negative protein in mouse oocytes, we mixed mRNA encoding
wild-type or mutant truncated CPEB D N (Fig. 5) together with
radiolabeled cyclin B1 3 ¢ UTR and injected them into oocytes.
The oocytes were held in the immature stage with IBMX for
~6 hours, to allow for sufficient synthesis of the exogenous
CPEB, which was followed by incubation in IBMX-free
medium to allow maturation to proceed. The RNA was then
extracted and polyadenylation was examined. Fig. 5
demonstrates that while injected wild-type CPEB had no
effect on cyclin RNA polyadenylation, CPEB D N almost
completely inhibited this process (less that ~10%
polyadenylation at MII compared with CPEB wild-type
injected, which was greater than 60% polyadenylation at the
same stage). However, this reduced polyadenylation by CPEB
D N somewhat surprisingly had little effect on meiotic
progression. We conclude that not only is CPEB necessary for
cytoplasmic polyadenylation in mouse oocytes, but that it
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Fig. 4. IAK1/Eg2 blocking peptide inhibits first polar body
extrusion. Oocytes were injected with the peptides noted in Fig. 3B,
except that in this case they were not coupled to ovalbumin. The rate
of polar body extrusion during maturation was assessed. While the
wild-type peptide only moderately inhibited polar body extrusion,
the mutant, alanine-containing peptide was more effective in doing
so. Although both peptides bind Eg2, the binding to the mutant
peptide is essentially irreversible, and thus it is a more effective
competitive inhibitor of kinase activity. In this analysis, 29 oocytes
were assessed for the wild-type peptide, 18 oocytes for the mutant
peptide and 47 oocytes that were not injected. The experiment was
performed twice.
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must also be phosphorylated at the LDS/TR motif by
IAK1/Eg2 for this process to occur.
DISCUSSION
The results presented in this study show that (1) all the key
polyadenylation factors are stored in the cytoplasm of mouse
oocytes; (2) the kinase IAK1/Eg2 is most likely activated upon
the induction of oocyte maturation; (3) IAK1/Eg2
phosphorylates CPEB serine 174; and (4) this phosphorylation
event is necessary for cytoplasmic polyadenylation during
meiotic maturation. These observations indicate that the main
functions of CPEB in mouse oocytes, to mask and activate
mRNA translation, are similar to those in Xenopus oocytes. For
example, the masking function of the CPE (ACE) in mouse
oocytes has been documented for tissue plasminogen activator
(tPA) (Stutz et al., 1997; Stutz et al., 1998) and cyclin B1 (Tay
et al., 2000) mRNAs. While the protein responsible for the tPA
mRNA repression is unknown, that which mediates cyclin
mRNA repression is clearly CPEB (Tay et al., 2000). The
demonstration in this report that maskin (or at least specific
maskin immunoreactivity) is present in the mouse oocyte
cytoplasm implies that this protein is the most proximal arbiter
of translation, via its interaction with CPEB and eIF4E
(Stebbins-Boaz et al., 1999). In addition, the findings that the
AAUAAA sequence is necessary for polyadenylation (Vassalli
et al., 1989) and that CPSF 100 kDa is cytoplasmic indicates
that, as in Xenopus oocytes, the multisubunit CPSF, which is
recruited to mRNA by CPEB, attracts poly(A) polymerase to
the end of the mRNA (Mendez et al., 2000b). Finally, because
IAK1/Eg2 activity is stimulated upon the induction of
maturation and because this kinase phosphorylates CPEB
Ser174, the signaling events that link an initial decrease in
cAMP (Eppig, 1991) to the polyadenylation machinery are at
least partly conserved between Xenopus and mouse.
CPEB functions during two distinct phases of
meiosis
Although mouse oocytes do not require protein synthesis to
enter or complete maturation, polyadenylation-induced
translation potentiates the rate of this process. In maturing
mouse oocytes, there are two phases of M-phase promoting
factor (MPF, a heterodimer of cdc2 and cyclin B) activity that
drive the MI and MII transitions. The increase in this activity
is regulated at the translational level (Hampl and Eppig,
1995b), which is, at least in part, due to the cytoplasmic
polyadenylation of cyclin B1 mRNA (Tay et al., 2000). The
findings presented in this study demonstrate that CPEB is
responsible for the translation of this mRNA. Another mRNA
whose polyadenylation-induced translation is essential for
proper meiotic progress encodes Mos, a serine/threonine
kinase. In mouse oocytes, Mos is a component of cytostatic
factor (CSF), a protein complex that arrests meiosis at MII. The
destruction of CSF activity by disruption of the Mos gene
results in a high incidence of parthenogenetic activation. In
these cases, the now mitotically dividing oocytes occasionally
fail to be ovulated and give rise to ovarian cysts and tumors
(Colledge et al., 1994; Hashimoto et al., 1994; Choi et al.,
1996). While mouse oocytes contain some Mos protein, they
also contain dormant CPE-containing Mos mRNA that, upon
the induction of maturation, undergoes polyadenylation-
induced translation. The destruction of Mos mRNA (O’Keefe
et al., 1989) or the abrogation of Mos mRNA polyadenylation
(Gebauer et al., 1994) prevents Mos synthesis, inhibits proper
MII arrest and can occasionally lead to parthenogenesis.
Therefore, the translational activation of Mos mRNA, by
CPEB-mediated polyadenylation, is necessary for the late
phase of oocyte meiosis.
CPEB function is also crucial at the pachytene stage of
prophase I. CPEB-deficient female mice are sterile because
they lack ovaries altogether, or contain only malformed
ovaries. Late stage embryos (18.5 dpc) contain ovaries, but they
are devoid of oocytes. Earlier embryonic ovaries (16.5 dpc) do
contain oocytes, but their chromatin is fragmented and/or
dispersed, suggesting a defect in synapsis or chromosome
pairing. While such oocytes contain wild-type levels of
mRNAs that encode two key components of the synaptonemal
complex (synaptonemal complex proteins 1 and 3), they are
not translated. These observations, plus the fact that these
mRNAs contain CPEs in their 3 ¢ UTRs that are bound by
CPEB both in vitro and in vivo, demonstrate that the regulated
translation of synaptonemal complex protein mRNAs by CPEB
is essential for progression through first meiotic prophase (J.
T. and J. D. R., unpublished).
Oh et al. have shown that cytoplasmic polyadenylation of
CPE-containing mRNAs occurs after fertilization in the mouse,
which suggests that maternally inherited sequences may play
an important, but heretofore unknown role in the embryo of
this species (Oh et al., 2000; see also Tong et al., 2000).
However, whether embryonic polyadenylation is CPEB
dependent is unclear because Tay et al. have been unable to
detect this protein in the fertilized egg (Tay et al., 2000).
Furthermore, if only a small amount of CPEB remains stable
after fertilization (e.g. ~10%), as is the case in Xenopus
(Groisman et al., 2000), then it would not necessarily have been
detected, and thus could promote cytoplasmic polyadenylation
in the embryo (see below). Clearly, additional experiments are
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Fig. 5. CPEB is required for cytoplasmic polyadenylation. GV stage
oocytes were injected with a mixture of radiolabeled cyclin B1 3¢
UTR and mRNA encoding either wild-type CPEB or a mutant CPEB
(D N) that lacks the N-terminal 146 amino acids. Both proteins
contain the two LDSR motifs, as well as the RNA recognition motifs
(RRM) and zinc finger (ZF) that are necessary for RNA binding
(Hake et al., 1998). The RNA was then extracted from maturing
oocytes and the polyadenylation of the cyclin B1 3 ¢ UTR was
analyzed by denaturing PAGE and phosphorimaging.
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required to determine whether CPEB is involved embryonic
polyadenylation.
A conserved signaling pathway promotes oocyte
maturation
In Xenopus oocytes exposed to progesterone, the natural
inducer of maturation, a transient but essential decrease in
cAMP is followed by the activation of Eg2 (Andresson and
Ruderman, 1998). Decreased cAMP is also necessary for
mouse oocyte maturation, which in this case is followed by the
activation of IAK1. It seems likely that IAK1/Eg2 is itself
activated by phosphorylation, and the kinase responsible is
almost certainly the same in mouse and Xenopus. IAK1/Eg2
then becomes localized at spindles and centrosomes, where it
may be involved in the assembly of these structures (Nigg,
2001). However, as noted above, no CPEB or maskin can be
detected after fertilization. Therefore, while the signaling
events leading to translational activation during oocyte
maturation are conserved among vertebrates, the events that
control translation after fertilization may be quite different, and
could reflect the relative importance of maternally inherited
mRNA.
We thank Mary Jo Carabatsos for advice on immunostaining mouse
oocytes, Jim Manley and Joan Ruderman for antibodies, and Joan
Ruderman for the recombinant Eg2. J. T. was supported in part by an
NIH Institutional Postdoctoral Training Grant (HD07349) and R. M.
was supported by a Special Fellowship from the Leukemia and
Lymphoma Society of America. This work was funded by a grant
from the NIH (HD37267).
REFERENCES
Andresson, T. and Ruderman, J. V. (1998). The kinase Eg2 is a component
of the Xenopus oocyte progesterone-activated signaling pathway. EMBO J.
17, 5627-5237.
Bilger, A., Fox, C. A., Wahle, E. and Wickens, M. (1994). Nuclear
polyadenylation factors recognize cytoplasmic polyadenylation elements.
Genes Dev. 8, 1106-1116.
Boyle, W. J., van der Geer, P. and Hunter, T. (1991). Phosphopeptide
mapping and phosphoamino acid analysis by two-dimensional separation on
thin-layer cellulose plates. Methods Enzymol. 201, 110-149.
Carrera, P., Johnstone, O., Nakamura, A., Casanova, J., Jackle, H. and
Lasko, P. (2000). VASA mediates translation through interaction with a
Drosophila yIF2 homolog. Mol. Cell 5, 181-187
Choi, T., Rulong, S., Resau, J., Fukasawa, K., Matten, W., Kuriyama, R.,
Mansour, S., Ahn, N. and Vande Woude, G. F. (1996). Mos/mitogen-
activated protein kinase can induce early meiotic phenotypes in the absence
of maturation-promoting factor: a novel system for analyzing spindle
formation during meiosis I. Proc. Natl. Acad. Sci. USA 93, 4730-4735.
Colledge, W. H., Carlton, M. B., Udy, G. B. and Evans, M. J. (1994).
Disruption of c-mos causes parthenogenetic development of unfertilized
mouse eggs. Nature 370, 65-68.
de Moor C. H. and Richter, J. D. (1999). Cytoplasmic polyadenylation
elements mediate masking and unmasking of cyclin B1 mRNA. EMBO J.
18, 2294-2303.
Dickson, K. S., Bilger, A., Ballantyne, S. and Wickens, M. P. (1999). The
cleavage and polyadenylation specificity factor in Xenopus laevis oocytes is
a cytoplasmic factor involved in regulated polyadenylation. Mol. Cell. Biol.
19, 5707-5717.
Eppig, J. J. (1991). Intercommunication between mammalian oocytes and
companion somatic cells. BioEssays 13, 569-574.
Fox, C. A., Sheets, M. D. and Wickens, M. P. (1989). Poly(A) addition during
maturation of frog oocytes: distinct nuclear and cytoplasmic activities and
regulation by the sequence UUUUUAU. Genes Dev. 3, 2151-2162.
Gebauer, F. and Richter, J. D. (1996). Mouse cytoplasmic polyadenylylation
element binding protein: an evolutionarily conserved protein that interacts
with the cytoplasmic polyadenylylation elements of c-mos mRNA. Proc.
Natl. Acad. Sci. USA 93, 14602-14607.
Gebauer, F. and Richter, J. D. (1995). Cloning and characterization of a
Xenopus poly(A) polymerase. Mol. Cell. Biol. 15, 1422-1430.
Gebauer, F., Xu, W. Cooper, G. M., and Richter, J. D. (1994). Translational
control by cytoplasmic polyadenylation of c-mos mRNA is necessary for
oocyte maturation in the mouse. EMBO J. 13, 5712-5720.
Giet, R. and Prigent, C. (1999). Aurora/Ipl1p-related kinases, a new
oncogenic family of mitotic serine-threonine kinases. J. Cell Sci. 112, 3591-
3601.
Gingras, A. C., Raught, B. and Sonenberg, N. (1999). eIF4 initiation factors:
effectors of mRNA recruitment to ribosomes and regulators of translation.
Annu. Rev. Biochem. 68, 913-963.
Groisman, I., Huang, Y. S., Mendez, R., Cao, Q., Theurkauf, W. and
Richter, J. D. (2000). CPEB, maskin, and cyclin B1 mRNA at the mitotic
apparatus: implications for local translational control of cell division. Cell
103, 435-447.
Hake, L. E. and Richter, J. D. (1994). CPEB is a specificity factor that
mediates cytoplasmic polyadenylation during Xenopus oocyte maturation.
Cell 79, 617-627.
Hake, L. E, Mendez, R. and Richter, J. D. (1998). Specificity of RNA
binding by CPEB: requirement for RNA recognition motifs and a novel zinc
finger. Mol. Cell. Biol. 18, 685-693.
Hampl, A. and Eppig, J. J. (1995a). Analysis of the mechanism(s) of
metaphase I arrest in maturing mouse oocytes. Development 121, 925-933.
Hampl, A. and Eppig, J. J. (1995b). Translational regulation of the gradual
increase in histone H1 kinase activity in maturing mouse oocytes. Mol.
Reprod. Dev. 40, 9-15.
Hashimoto, N., Watanabe, N., Furuta, Y., Tamemoto, H., Sagata, N.,
Yokoyama, M., Okazaki, K., Nagayoshi, M., Takeda, N., Ikawa Y, et al.
(1994). Parthenogenetic activation of oocytes in c-mos-deficient mice.
Nature 370, 68-71.
Huarte, J., Belin, D., Vassalli, A., Strickland, S. and Vassalli, J. D. (1987).
Meiotic maturation of mouse oocytes triggers the translation and
polyadenylation of dormant tissue-type plasminogen activator mRNA.
Genes Dev. 1, 1201-1211.
Kuge, H. and Richter, J. D. (1995). Cytoplasmic 3 ¢ poly(A) addition induces
5¢ cap ribose methylation: implications for translational control of maternal
mRNA. EMBO J. 14, 6301-6310.
McGrew, L. L., Dworkin-Rastl, E., Dworkin, M. B. and Richter, J. D.
(1989). Poly(A) elongation during Xenopus oocyte maturation is required
for translational recruitment and is mediated by a short sequence element.
Genes Dev. 3, 803-815.
Mendez, R., Hake, L. E. andresson, T., Littlepage, L. E., Ruderman, J. V.
and Richter, J. D. (2000a). Phosphorylation of CPE binding factor by Eg2
regulates translation of c-mos mRNA. Nature 404, 302-307.
Mendez, R., Murthy, K. G., Ryan, K., Manley, J. L. and Richter, J. D.
(2000b). Phosphorylation of CPEB by Eg2 mediates the recruitment of
CPSF into an active cytoplasmic polyadenylation complex. Mol. Cell 6,
1253-1259.
Messinger, S. M. and Albertini, D. F. (1991). Centrosome and microtubule
dynamics during meiotic progression in the mouse oocyte. J. Cell Sci. 100,
289-298.
Nigg, E. A. (2001). Mitotic kinases as regulators of cell division and its
checkpoints. Nat. Rev. Mol. Cell. Biol. 2, 21-33.
Oh, B., Hwang, S., McLaughlin, J., Solter, D. and Knowles, B. B. (2000).
Timely translation during the mouse oocyte-to-embryo transition.
Development 127, 3795-3803.
O’Keefe, S. J., Wolfes, H., Kiessling, A. A. and Cooper, G. M. (1989).
Microinjection of antisense c-mos oligonucleotides prevents meiosis II in
the maturing mouse egg. Proc. Natl. Acad. Sci. USA 86, 7038-7042.
Paris, J., Swenson, K., Piwnica-Worms, H. and Richter, J. D. (1991).
Maturation-specific polyadenylation: in vitro activation by p34cdc2 and
phosphorylation of a 58-kD CPE-binding protein. Genes Dev. 5, 1697-
1708.
Salles, F. J., Lieberfarb, M. E., Wreden, C., Gergen, J. P. and Strickland,
S. (1994). Coordinate initiation of Drosophila development by regulated
polyadenylation of maternal messenger RNAs. Science 266, 1996-1999.
Schroeder, K. E., Condic, M. L., Eisenberg, L. M. and Yost, H. J. (1999).
Spatially regulated translation in embryos: asymmetric expression of
maternal Wnt-11 along the dorsal-ventral axis in Xenopus. Dev. Biol. 214,
288-297.
Sheets, M. D., Fox, C. A., Hunt, T., Vande Woude, G. and Wickens, M.
(1994). The 3 ¢ -untranslated regions of c-mos and cyclin mRNAs stimulate
2822
translation by regulating cytoplasmic polyadenylation. Genes Dev. 8, 926-
938.
Sheets, M. D., Wu, M. and Wickens, M. (1995). Polyadenylation of c-mos
mRNA as a control point in Xenopus meiotic maturation. Nature 374, 511-
516.
Simon, R., Wu, L. and Richter, J. D. (1996). Cytoplasmic polyadenylation
of activin receptor mRNA and the control of pattern formation in Xenopus
development. Dev. Biol. 179, 239-250.
Stebbins-Boaz, B., Hake, L. E. and Richter, J. D. (1996). CPEB controls the
cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is
necessary for oocyte maturation in Xenopus. EMBO J. 15, 2582-2592.
Stebbins-Boaz, B., Cao, Q., de Moor, C. H., Mendez, R. and Richter, J. D.
(1999). Maskin is a CPEB-associated factor that transiently interacts with
elF-4E. Mol. Cell 4, 1017-1027.
Stutz, A., Huarte, J., Gubler, P., Conne, B., Belin, D. and Vassalli, J. D.
(1997). In vivo antisense oligodeoxynucleotide mapping reveals masked
regulatory elements in an mRNA dormant in mouse oocytes. Mol. Cell. Biol.
17, 1759-1767
Stutz, A., Conne, B., Huarte, J., Gubler, P., Volkel, V., Flandin, P. and
Vassalli, J. D. (1998). Masking, unmasking, and regulated polyadenylation
cooperate in the translational control of a dormant mRNA in mouse oocytes.
Genes Dev. 12, 2535-2548.
Tay, J., Hodgman, R. and Richter, J. D. (2000). The control of cyclin B1
mRNA translation during mouse oocyte maturation. Dev. Biol. 221, 1-9.
Tong, Z., Gold, L., Pfeifer, K. E., Dorward, H., Lee, E., Bondy, C. A., Dean,
J. and Nelson, L. M. (2000). Mater, a maternal effect gene required for
early embryonic development in mice. Nat. Genet. 26, 267-268.
Uto K. and Sagata, N. (2000). Nek2B, a novel maternal form of Nek2 kinase,
is essential for the assembly or maintenance of centrosomes in early
Xenopus embryos. EMBO J. 19, 1816-1826.
Vassalli, J. D., Huarte, J., Belin, D., Gubler, P., Vassalli, A., O’Connell, M.
L., Parton, L. A., Rickles, R. J. and Strickland, S. (1989). Regulated
polyadenylation controls mRNA translation during meiotic maturation of
mouse oocytes. Genes Dev. 3, 2163-2171.
Wu, L., Good, P. J. and Richter, J. D. (1997). The 36-kilodalton embryonic-
type cytoplasmic polyadenylation element-binding protein in Xenopus laevis
is ElrA, a member of the ELAV family of RNA-binding proteins. Mol. Cell.
Biol. 17, 6402-6409.
R. Hodgman and others
